Original Research

MAFLD is Associated with the Risk of Liver Fibrosis and Inflammatory Activity in HBeAg-Negative CHB Patients

Chen X, Zhou J, Wu L, Zhu X, Deng H

Diabetes, Metabolic Syndrome and Obesity 2022, 15:673-683

Published Date: 1 March 2022